Updated data from a trial of Johnson & Johnson’s experimental “pretzel” showed that more than 80% of bladder ...
A group of Democratic and Republican senators introduced a bill on Thursday that calls for $275 million toward federal ...
(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) Piction Health, which ...
Sarepta Therapeutics’ chief scientist suggested that the FDA was ahead of schedule in reviewing the company’s application to ...
Pacific Biosciences is letting go of 190 employees, according to the company, as part of cost-cutting measures after ...
For biosimilars to win, AbbVie has to lose, according to Boehringer Ingelheim. The German drugmaker on Wednesday said that ...
Jang-Ho Cha had no interest in leaving his post at Novartis, where he led translational medicine for the pharma giant’s work ...
The new round of letters targets 20 products and follows a push by the FTC last year to go after patents on asthma ...
Chroma Medicine laid off an undisclosed number of employees earlier this week, as the privately held startup focuses its ...
GSK wants to present Blenrep to regulatory bodies sooner. The UK pharma will submit Blenrep in second-line multiple myeloma ...
Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and ...
Novartis is looking to build on its radiopharma research machinery. The maker of Lutathera and Pluvicto has expanded its ...